AN2 Therapeutics, Inc.ANTXNASDAQ
Loading
PB Ratio: Discounted ValuationCompressed
Percentile Rank17
3Y CAGR-24.9%
5Y CAGR-63.8%
Year-over-Year Change
Price-to-book ratio
3Y CAGR
-24.9%/yr
Annual compound
5Y CAGR
-63.8%/yr
Recent acceleration
Percentile
P17
Within normal range
vs 5Y Ago
0x
Contraction
Streak
1 yr
Consecutive growthCompressed
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 0.65 | +29.1% |
| 2024 | 0.50 | -87.0% |
| 2023 | 3.88 | +153.0% |
| 2022 | 1.53 | -67.1% |
| 2021 | 4.66 | -95.6% |
| 2020 | 104.91 | +75.0% |
| 2019 | 59.96 | - |